Stephen Clarke
Impact in
- Oncology top 0.05%
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 198
- Colorectal Cancer Treatments and Studies 57
- Cancer Treatment and Pharmacology 40
- Inflammatory Biomarkers in Disease Prognosis 29
- Cancer Immunotherapy and Biomarkers 27
- Pancreatic and Hepatic Oncology Research 25
- Lung Cancer Research Studies 21
-
- Lung Cancer Treatments and Mutations 47
- Occupational and environmental lung diseases 23
- Co-authors
- Kellie A. Charles (24 shared papers)Donald C. McMillan (4 shared papers)Connie I. Diakos (30 shared papers)Laurent P. Rivory (31 shared papers)Nick Pavlakis (94 shared papers)Leonard B. Saltz (9 shared papers)Paul G. Horgan (2 shared papers)Eduardo Díaz‐Rubio (7 shared papers)
- Journals
- Journal of Clinical Oncology (59 papers)Annals of Oncology (21 papers)British Journal of Cancer (14 papers)Lung Cancer (11 papers)PLoS ONE (7 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Stephen Clarke
460 papers receiving 21.3k citations
Stephen Clarke's Hit Papers
Peers
Comparison fields: 5 of 202
- Oncology 9.9k
- Hepatology 1.1k
- Cancer Research 2.0k
- Pulmonary and Respiratory Medicine 3.6k
- Pharmacology 684
Countries citing papers authored by Stephen Clarke
This map shows the geographic impact of Stephen Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Clarke more than expected).
Fields of papers citing papers by Stephen Clarke
This network shows the impact of papers produced by Stephen Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Clarke. The network helps show where Stephen Clarke may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Clarke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 477 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study Hit paper breakdown → | 2008 | 2286 |
| 2 | Cancer-related inflammation and treatment effectiveness Hit paper breakdown → | 2014 | 1716 |
| 3 | The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer Hit paper breakdown → | 2013 | 1207 |
| 4 | Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 655 |
| 5 | Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study Hit paper breakdown → | 2017 | 551 |
| 6 | 2011 | 401 | |
| 7 | 2012 | 398 | |
| 8 | 1999 | 371 | |
| 9 | 2012 | 356 | |
| 10 | 2008 | 313 | |
| 11 | Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review Hit paper breakdown → | 2012 | 275 |
| 12 | 2010 | 269 | |
| 13 | 2016 | 252 | |
| 14 | 2017 | 215 | |
| 15 | 2015 | 199 | |
| 16 | 2010 | 197 | |
| 17 | 2016 | 188 | |
| 18 | 2003 | 186 | |
| 19 | 2008 | 184 | |
| 20 | 1979 | 182 |
About Stephen Clarke
Stephen Clarke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 477 papers that have together received 21.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (57 papers), Lung Cancer Treatments and Mutations (47 papers), Cancer Treatment and Pharmacology (40 papers), Inflammatory Biomarkers in Disease Prognosis (29 papers), Cancer Immunotherapy and Biomarkers (27 papers), Pancreatic and Hepatic Oncology Research (25 papers), Occupational and environmental lung diseases (23 papers) and Lung Cancer Research Studies (21 papers). The work is most often cited by research in Oncology (9.9k citations), Hepatology (1.1k citations), Cancer Research (2.0k citations), Pulmonary and Respiratory Medicine (3.6k citations) and Pharmacology (684 citations). Stephen Clarke has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kellie A. Charles, Donald C. McMillan, Connie I. Diakos, Laurent P. Rivory, Nick Pavlakis, Leonard B. Saltz, Paul G. Horgan, Eduardo Díaz‐Rubio, Arié Figer and Sheryl Koski. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Lung Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.